Improved translation of Nav1.5 channel inhibition to in vivo QRS interval prolongation via the hIPSC cardiomyocyte model

Download

Authors: John P. Imredy, Holly Clouse, Mei Zhang, Spencer Dech, Qiuwei Xu, Jeremy Ellis, Shaun Gruver, Julia C. Hotek, and Christopher P. Regan

Journal of Pharmacological and Toxicological Methods, 13 July 2025

Related Resources
SNTA1-deficient human cardiomyocytes show shorter field potential duration and slower conduction velocity
Development and validation of dual-cardiotoxicity evaluation method based on analysis of field potential and contractile force of human iPSC-derived cardiomyocytes / multielectrode assay platform
The three-dimensionality of the hiPSC-CM spheroid contributes to the variability of the field potential

Related Products

System

Maestro Pro

High-throughput MEA and live-cell analysis system

Learn more >>
Axion BioSystems Maestro Pro MEA system
Software

Cardiac Module

Record the four key measures of cardiac performance: action potential, field potential, propagation, and contractility

Learn more >>
Axion BioSystems Cardiac software Module for MEA experiments
Consumable

CytoView MEA Plate

The premium Maestro MEA plate with a transparent well bottom for cell visualization and assay multiplexing

Learn more >>
Axion BioSystems CytoView MEA plate